secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALNYLAM PHARMACEUTICALS, INC. (ALNY)
CIK:        0001178670
Form:       8-K
Filed at:   2024-01-19T23:59:59+00:00
Accession:  0001193125-24-011278
Event type: leadership
Sentiment:  negative
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alnylam EVP & Chief Legal Officer Indrani Franchini to depart March 1, 2024
---------------------------------------------------------------------------

- Indrani L. Franchini to transition from EVP, Chief Legal Officer and Secretary effective March 1, 2024.
- Mutual agreement reached on January 12, 2024; severance terms to be formalized in a written agreement on or before the separation date.
- No replacement has been named for the Chief Legal Officer and Secretary role.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178670/000119312524011278/0001193125-24-011278-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178670/000119312524011278/d701085d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-011278

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer